β ‐Glucan Subverts the Function of Myeloid Cells in Neonates
Journal of Immunology Research · 2024
DOI: 10.1155/2024/2765001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology Research, 2024. Verfasst von Yingying Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Immunology, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangdong Provincial Key Laboratory of Allergy and Cl…. Hauptthemen laut MEDLINE: Animals, Newborn, Arginase, beta-Glucans, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
β ‐Glucan is the main component of the cell wall of pathogen‐associated molecular patterns (PAMPs) including various yeast, fungi, or certain bacteria. Previous reports demonstrated that β ‐glucan was widely investigated as a potent immunomodulators to stimulate innate and adaptive immune responses, which indicated that it could be recommended as an effective adjuvant in immunotherapy. However, the detailed effects of β ‐glucan on neonatal immunity are still largely unknown. Here, we found that β ‐glucan did not affect the frequencies and numbers of myeloid cells in the spleen and bone marrow from neonates. Functional assay revealed that β ‐glucan from neonates compromised the immunosuppressive function of immature myeloid cells, which were myeloid‐derived suppressor cells (MDSCs). Flow cytometry or gene expression analysis revealed that β ‐glucan‐derived polymorphonuclear (PMN)‐MDSCs produced lower level of reactive oxygen species (ROS) and arginase‐1 ( Arg1 ) in neonatal mice. Furthermore, β ‐glucan administration significantly decreased the frequency and ROS level of PMN‐MDSCs in vitro. These observations suggest that β ‐glucan facilitates the maturation of myeloid cells in early life, which may contribute to its beneficial effects against immune disorders later in life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Immunology, Sino-French Hoffmann Institute, School of Basic Medical Sciences, Guangdong Provincial Key Laboratory of Allergy and Clinical Immunology, The Second Affiliated Hospital, Guangzhou Medical U…
- Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510000, China.
- Department of Clinical Laboratory, The Key Laboratory of Advanced Interdisciplinary Studies Center, The First Affiliated Hospital of Guangzhou Medical University, National Center for Respiratory Medicine, National Clini…
- Tianjin Institute of Immunology, Key Laboratory of Immune Microenvironment and Disease of the Ministry of Education, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070…
ORCID-Profile: Yingying Chen, Hui Li, Lin Zhu, Quan Yang, Jie Zhou
Förderung
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Chen, Y., Li, H., Zhu, L., Yang, Q., & Zhou, J. (2024). β ‐Glucan Subverts the Function of Myeloid Cells in Neonates. Journal of Immunology Research. https://doi.org/10.1155/2024/2765001
Vancouver
Chen Y, Li H, Zhu L, Yang Q, Zhou J. β ‐Glucan Subverts the Function of Myeloid Cells in Neonates. Journal of Immunology Research. 2024. doi:10.1155/2024/2765001
BibTeX
@article{Chen2024,
author = {Chen, Yingying and Li, Hui and Zhu, Lin and Yang, Quan and Zhou, Jie},
title = {β ‐Glucan Subverts the Function of Myeloid Cells in Neonates},
journal = {Journal of Immunology Research},
year = {2024},
doi = {10.1155/2024/2765001}
}
EUVIMED